Neil King and David Veesler of the UW School of Medicine discuss their efforts in designing a new COVID-19 vaccine.
April 25, 2022

A new COVID-19 vaccine developed at the University of Washington School of Medicine was shown to be safe and effective during a multinational trial of more than 4,000 adults.

April 25, 2022

A Phase 3 clinical trial found that the second-generation vaccine generates high levels of neutralizing antibodies.

March 3, 2022

Cryoelectron microscopy studies of Nipah and Hendra viruses may lead to ideas for vaccine design and antibody treatments.

January 7, 2022

The antibody closely mimics the binding site that the SARS-CoV-2 virus uses to infect cells, and seemingly thwarts invasion via mutation.

December 27, 2021

Findings could lead to the development of more effective vaccines and antibody treatments for COVID-19 variants.

November 9, 2021

Molecular research uncovers how these SARS-CoV-2 variants can erode vaccine immunity.

July 2, 2021

Studies reveal unprecedented mechanism behind loss of antibody neutralization against this pandemic coronavirus variant of concern.

March 17, 2021

Antibodies from recovered patients recognize a lesser-known site on the pandemic coronavirus and block infection in lab studies


October 30, 2020

Preclinical data published in Cell show the nanoparticle vaccine spurs extremely high levels of protective antibodies in animal models.

August 24, 2020

The AIDS Clinical Trials Unit at UW Medicine is seeking participants recently infected with the virus.



Subscribe to antibodies